Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ·Healthcare·Biotechnology
$24.54
+2.29%
Mkt Cap $2.37B
Analyst Ratings
No recent rating data.
Price Target (40 analysts)
$49.90
Range $34.00 – $63.00
Implied Upside
+103.3%
Consensus $49.90 vs current $24.54